Your browser doesn't support javascript.
loading
Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments.
Wang, Debby D; Ma, Lichun; Wong, Maria P; Lee, Victor H F; Yan, Hong.
  • Wang DD; Department of Electronic Engineering, City University of Hong Kong, Kowloon, Hong Kong.
  • Ma L; Department of Electronic Engineering, City University of Hong Kong, Kowloon, Hong Kong.
  • Wong MP; Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
  • Lee VH; Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
  • Yan H; Department of Electronic Engineering, City University of Hong Kong, Kowloon, Hong Kong.
PLoS One ; 10(5): e0128360, 2015.
Article en En | MEDLINE | ID: mdl-25993617

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinazolinas / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Receptor ErbB-3 / Multimerización de Proteína / Receptores ErbB / Clorhidrato de Erlotinib / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinazolinas / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Receptor ErbB-3 / Multimerización de Proteína / Receptores ErbB / Clorhidrato de Erlotinib / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2015 Tipo del documento: Article